Cite

    Farkowski, M. et al. (2019). Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness (AntaEP Study). British journal of clinical pharmacology. 85 (7), pp. 1552-1558. [Online].